Ultralow Dose PET Imaging for Bone Conditions

Ultralow Dose PET Imaging for 18F-NaF Uptake

Recruiting Phase 2 Interventional Study
Healthy Volunteer Bone Alteration Bone and Joint Cancer Bone and Joint Infection Arthritis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 120
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Diagnostic
Participants needed
200 (estimated)
Sponsor
Akiva Mintz · Other
Who this trial is looking for

This trial is looking for adults to test a new imaging technique for monitoring bone health. Participants will receive a small injection and undergo imaging for about three hours.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 18 years old.
  • I can give my consent and follow the study rules.
  • I am not pregnant or breastfeeding.
  • I have a negative pregnancy test if I can become pregnant.

You may not be able to join if

  • I have had too much radiation exposure from previous scans.
  • I have participated in this study more than four times.
  • I suffer from severe claustrophobia or chronic pain.
  • I cannot complete the PET scan due to my musculoskeletal conditions.
  • I am currently on treatments that could affect the results.
  • I cannot provide informed consent.
  • My health condition might make the study unsafe.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate an investigational ultralow dose positron emission tomography (PET imaging) technique for increased bone turnover that is found in diseases such as cancer, trauma, infection, arthritis, and other benign diseases of bone detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and imag…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥18 years. * Ability to provide informed consent and comply with study procedures. * For female participants: Must not be pregnant or breastfeeding; Negative pregnancy test required for women of childbearing potential. Exclusion Criteria: * Participants who have exceeded…
Contacts

Barbara Blanchfield

973-255-4955

bblanchfield@nii.org

CONTACT